In a new interview with journalist Marcel Clarke for Clarke’s Closer Look, OCRA grantee Dr. Daniel Heller of Memorial Sloan Kettering Cancer Center discusses how his lab is utilizing artificial intelligence (AI) to develop a cutting-edge blood test to detect ovarian cancer at its earliest stages. This OCRA-funded study is in partnership with Microsoft AI for Health.

Dr. Heller’s grant was made possible in part by generous donations from The Edmée Firth Fund for Research in Ovarian Cancer (EFFROC), and The Teal Foundation.